Home/Recalls/FDA-Z-1084-2026
FDA DevicesClass II

Asserachrom HPIA. Model/Catalog Number: 00615. The Asserachrom HPIA kit is ...

Published: January 21, 2026Recall ID: Z-1084-2026Category: devicesCountry: US

Reason for Recall / Hazard

Potential for defect for Asserachrom HPIA lot 271288, which can affect every well in the impacted strip and produce negative results.

Product Description & Identification

Asserachrom HPIA. Model/Catalog Number: 00615. The Asserachrom HPIA kit is intended for the qualitative detection in plasma or serum of the anti-heparin-platelet factor 4 (PF4) antibodies generated during the type II heparin-induced thrombocytopenia (HIT type II) by ELISA.

Affected Products

Asserachrom HPIA. Model/Catalog Number: 00615. The Asserachrom HPIA kit is intended for the qualitative detection in plasma or serum of the anti-heparin-platelet factor 4 (PF4) antibodies generated during the type II heparin-induced thrombocytopenia (HIT type II) by ELISA.

Additional Source Details

FieldValue
CityParsippany
StateNJ
Event id98163
Address 15 Century Dr
Code infoReference Number: 00615. UDI: (01)03607450006155(11)240531(17)260531(10)271288(241)00615. Lot Number: 271288.
Postal code07054-4607
Report date20260121
Product typeDevices
Product quantity438 units
Reason for recallPotential for defect for Asserachrom HPIA lot 271288, which can affect every well in the impacted strip and produce negative results.
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20251215
Initial firm notificationE-Mail
Center classification date20260114

Overview

  • Recalling FirmDiagnostica Stago, Inc.
  • StatusOngoing
  • Risk LevelClass II
  • DistributionWorldwide - US Nationwide distribution in the states of AL, CA, FL, GA, HI, IA, MA, MI, NJ, NV, NY, OH, TN, WI and the countries of Belgium, Canada, Denmark, Algeria, Spain, Finland, France, Great Britain, Italy, Lebanon, Saudi Arabia, Uganda.
Official Agency Alert